Abstract: Fever (also known as pyrexia, from the Greek pyretos meaning Fire, or a febrile response, from the Latin word febris, meaning fever, and archaically known as ague) is a frequent medical sign that describes an increase in internal body temperature to levels above normal. Fever is most accurately characterized as a temporary elevation in the body"s thermoregulatory set-point, usually by about 1 -2 °C (1.8-3.6 °F). Fever is caused by an elevation in the thermoregulatory set-point, causing typical body temperature (generally and problematically considered to be 37 °C or 98.6 °F: see below for specifics) to rise, and effector mechanisms are enacted as a result. A feverish individual has a general feeling of cold despite an increased body temperature, and increases in heart rate, muscle tone and shivering, all of which are caused by the body"s attempts to counteract the newly-perceived hypothermia and reach the new thermoregulatory set-point Ayurvedic treatment through skin exposure by fabrics dyed in medicinal herb dyes is very ancient technique for ayurvedic treatment as the skin received the medicinal benefits of these herbs through the exposure to clothing, bedding, or coir mats When vastra exposed to skin, the herbs are absorbed into the body and function as a means of providing ayurvedic treatment for a broad range of diseases including Fever.Allergy and excessive heat and cold. It is also known to strengthen the immune system. Experimental research confirms that medicinal plant pigment dyeing of organic natural fiber helps in treating and preventing the Fever, Allergy and excessive heat and cold.
FIELD OF THE INVENTION
This invention relates to novel textiles for Fever, Allergy and excessive heat and
cold, made from organic cotton, coloring and coating with different natural colour derived from various medicinal plants describes in ayurvedic text . Fever (also known as pyrexia, from the Greek pyretos meaning fire, or a febrile response, from the Latin word febris, meaning fever, and archaically known as ague) is a frequent medical sign that describes an increase in internal body temperature to levels above normal. Fever is most accurately characterized as a temporary elevation in the body's thermoregulatory set-point, usually by about 1-2 °C (1.8-3.6 °F).
Fever is caused by an elevation in the thermoregulatory set-point, causing typical body temperature (generally and problematically considered to be 37 °C or 98.6 °F; see below for specifics) to rise, and effector mechanisms are enacted as a result. A feverish individual has a general feeling of cold despite an increased body temperature, and increases in heart rate, muscle tone and shivering, all of which are caused by the body's attempts to counteract the newly-perceived hypothermia and reach the new thermoregulatory set-point
BACKGROUND OF THE INVENTION
Ayurvedic treatment through skin exposure to fabrics dyed in medicinal herb dyes is very ancient technique for ayurvedic treatment as the skin received the medicinal benefits of these herbs through the exposure to clothing, bedding, or coir mats
When vastra exposed to skin, the herbs are absorbed into the body and function as a means of providing ayurvedic treatment for a broad range of diseases including Fever.Allergy and excessive heat and cold. It is also known to strengthen the immune system. Experimental research confirms that medicinal plant pigment dyeing of organic natural fiber helps in treating and preventing the Fever, Allergy and excessive heat and cold.
Novel textiles for treating and preventing the Skin disease, made from organic cotton, coloring and coating with different natural colour derived from various medicinal plants describes in ayurvedic text is the natural fiber which colored with natural dye.
Currently existing garments products, such as shirt, trousers, skirt, sari etc, are made from non coated fibers and do not include any bioactive coating agent applied topically to the fiber which have effect on Fever, Allergy and excessive heat and cold by controlled release processes by the cloth media surface during normal use through the skin .However, till the date none of garments individually demonstrate a therapeutic effect by skin absorption on prevention and treatment of Skin disease .
SUMMARY OF THE INVENTION
In the present invention we have used Leucas cephalotes and Ocimum plant for the preparation of the fabric, coating of the fabric and dying of the fabric by most bioactive materials from above two plants.
Our body can loses toxins and its metabolism can be enhanced by wearing the therapeutic clothing. Conventional Western medicine and traditional Eastern medicine recognize the skin as being the body's largest organ. The skin can act as a barrier but also as a conduit for outside substances to enter the body. Many environmental toxins and chemicals in conventional clothing are assimilated into the body through the skin. Anything which can improve the skin's natural ability-to block and resist harmful chemicals and toxins from entering the body will be beneficial to health.
Ayurveda identifies seven unique layers of the skin where each layer has a distinct function. Starting from the outermost layer, the seven layers defined by Ayurveda are Avabhasini. Lohita. Shweta. Tamra. Vedini, Rohini and Mamsadhara.
The fourth la\er. Tamra. supports the immune system and performs the function of acting as a barrier. Skin infections reflect an imbalance in this layer. The fabric of the present invention was improving the skin's ability to act as a barrier to external and environmental toxins; the wearer's health was improved.
Now that a connection has been established between exposure to intense sunlight and the skin, many people are protecting themselves against overexposure to the sun by using what are called sunscreen agents, which contain UV filters or
absorbers. The UV absorbers or UV filters are organic substances which are able to absorb electromagnetic radiation in the UV range.
The skin is an efficient barrier to the penetration of water soluble substances, and the rate of transdermal pharmaceutical agent absorption is primarily determined by the agent's lipid solubility, water solubility, and polarity. Highly polar or water soluble pharmaceutical agents are effectively blocked by the skin. Even very lipophilic pharmaceutical agents penetrate the dermis very slowly compared with the rate of penetration across cell membranes
Penetration Enhancers", in Transdermal Delivery of Drugs, Vol. II, Kyodonieus et al.. Eds., CRC Press, Boca Raton, Fla. Few pharmaceutical agents fit this profile and those which do are not always predictably absorbed. Various forms of chemical enhancers, such as those enhancing lipophilicity, have been developed to improve transdermal transport when physically mixed with certain therapeutic agents and provide more predictable absorption
The flowering annual herb Leucas cephalotes is a common weed which also has uses as an edible vegetable and herbal remedy. It has many common names, including guma. dronpushpi or drona puspi, and tou xu bai rong cao. It is a
common plant across Asia from China to the Indian subcontinent.
L. cephalotes springs up in cultivated fields as a weed, especially after a period of rain. It is collected for use as a leafy vegetable in rural areas. It is cultivated itself for its medicinal uses and is readily available in markets. One of the plant's most common historical uses has been as a treatment for snakebite. It is also steeped in water which is then used for bathing and for washing livestock.
Two biologically active compounds found in the plant are labellenic acid and beta-Sitosterol.
Leucas cephalotes (Roth.) Spreng. (Laminaceae) is an ayurvedic traditional medicinal plant used in India, Nepal and Pakistan to treat several ailments including diabetes. AIM OF THE STUDY: The aim of the present study is to investigate the antidiabetic, antihyperlipaemic and antioxidant activities of Leucas cephalotes for its purported use in diabetes. MATERIALS AND METHODS: The ethanol extract of leaves of Leucas cephalotes was administered (150, 300 and 450 mg kg(-l)bw) to diabetes induced (IDDM and NIDDM) rats and carbohydrate, lipid, antioxidant, urea and creatinine profiles were assessed. RESULTS: All the three doses of extract decreased plasma glucose and lipid profiles and, improved the antioxidant status of both types of diabetic rats. The extract administration improved hepatic glycogen content and hexokinase activity, decreased glucose-6-phosphatase activity, blood urea, creatinine contents and decreased lipid peroxidation in diabetic rats. Of the three doses used, 450 mg kg(-l)bw dose was found to be more potent in its effects comparable to those of glibenclamide and metformin. CONCLUSION: Leucas cephalotes regulates both carbohydrate and lipid metabolism and, improves body antioxidant defense systems in both types of diabetes
Ocimum tenuiflorum (also tulsi, tulasl, or Holy Basil) is an aromatic plant in the family Lamiaceae which is native throughout the Old World tropics and widespread as a cultivated plant and an escaped weed It is an erect, much branched subshrub 30-60 cm tall with hairy stems and simple opposite green leaves that are strongly scented. Leaves have petioles, and are ovate, up to 5 cm long, usually slightly toothed. Flowers are purplish in elongate racemes in close whorls. There
are two main morphotypes cultivated in India—green-leaved (Sri or Lakshmi tulsi) and purple-leaved (Krishna tulsi).
Tulsi has been used for thousands of years in Ayurveda for its diverse healing properties. It is mentioned by Charaka in the Charaka Samhita,[5] an ancient Ayurvedic text. Tulsi is considered to be an adaptogen,[6] balancing different processes in the body, and helpful for adapting to stress.[7] Marked by its strong aroma and astringent taste, it is regarded in Ayurveda as a kind of "elixir of life" and believed to promote longevity. [8]
Tulsi's extracts are used in ayurvedic remedies for common colds, headaches, stomach disorders, inflammation, heart disease, various forms of poisoning, and malaria. Traditionally, tulsi is taken in many forms: as herbal tea, dried powder, fresh leaf, or mixed with ghee. Essential oil extracted from Karpoora Tulsi is mostly used for medicinal purposes and in herbal cosmetics, and is widely used in skin preparations due to its anti-bacterial activity. For centuries, the dried leaves of Tulsi have been mixed with stored grains to repel insects.[9]
Recent studies suggest that Tulsi may be a COX-2 inhibitor, like many modern painkillers, due to its high concentration of eugenol (l-hydroxy-2-mefhoxy-4-allylbenzene).[10][11] One study showed Tulsi to be an effective treatment for diabetes by reducing blood glucose levels.[12] The same study showed significant reduction in total cholesterol levels with Tulsi. Another study showed that Tulsi's beneficial effect on blood glucose levels is due to its antioxidant properties. [13] Tulsi also shows some promise for protection from radiation poisoning[14] and cataracts.[15]
Some of the main chemical constituents of Tulsi are: Oleanolic acid, Ursolic acid, Rosmarinic acid, Eugenol, Carvacrol. Tinalool, and ß-caryophyllene.[6]
Example
Preparation of bioactive material from plants
1. Collection of the parts of the plants (leaves, barks, stems, flowers, fruits,
seeds).
2. Tested for the raw material for assessment of colour contents,
Extraction
The bioactive material extraction is broadly divided into extraction method &
extraction technology.
Aqueous Method:
Boil known amount plant stuff in 100 ml. of soft water at 100 C.
Filter the dye solution
Record the optical density
Alkaline Method:
Prepare 1% alkaline solution with addition of 1 g. Socium carbonate/Sodium
hydroxide in 100 ml. of water.
Enter the dye material and boil at 100 C.
Filter the dye solution
Record the optical density
Acidic Method
Prepare 1% of acidic solution by adding 1 ml. of HCL in 100 ml. of Soft water.
Enter the dye material and boil at 100 C.
Filter the dye solution
Record the optical density
Alcoholic Method
Add 50 ml. of alcohol to 50 ml. of water
Enter the dye material and boil
Filter the dye solution
We used the commen Extraction Technology such as Super Critical Fluid and Microwave Assisted Extraction Technology
According to the objective of the invention the process for making the fabric of the present invention entails steps which are substantially similar to current conventional processes for producing cotton, with the exception that the wood raw material used in the process of the present invention is a bioactive material from Leucas cephalotes and Ocimum .
In the present invention textiles was formed by weaving, knitting, crocheting, knotting of Leucas cephalotes and Ocimum plant fibers pressing together.
Before the spinning step, the wood pulp was mixed with cotton fibers. A preferred mixture is one in which the different fibers exist in a proportionate ratio of 20%-25% Leucas cephalotes and Ocimum fibers and 80% cotton fibers.
The fibers produced by the present invention have high strength, especially when wet, and good dimensional stabillity and firmness. In addition, the fibers produced by the process of the invention are highly absorbent
The fibers which result from the process of the present invention will be used in the manufacture of clothing, as medical fabrics.
Coating is a common technique used to apply dye particles onto textiles. The coating compositions that can modify the surface of textiles are usually composed of micro-particles, a surfactant, ingredients and a carrier medium. Several methods can apply coating onto fabrics, including spraying, transfer printing, washing, rinsing and padding. Of these methods, padding is the most commonly used. The
nano-particles are attached to the fabrics with the use of a padder adjusted to suitable pressure and speed, followed by drying and curing.
Coating enhance and extend the range of functional performance properties of textiles and the use of this techniques is growing rapidly as the applications for technical textiles become more diverse. Coating is a process in which a polymeric layer is applied directly to one or both surfaces of the fabric
• Coating can mostly be used of products which having capacity to convert in viscose liquid form. This viscose liquid so easily can spread over the surface and form coating.
• Drying or curing process which hardens the coating to produce a non blocking product.
• Due to viscosity requirement it is limited to linear polymers, which can be coated as a polymer melt or solution and on cooling, form a solid film or form solid film on evaporation of the solvent.
• There are some types of coatings that can be applied in the liquid form and then chemically cross-linked to form a solid-film.
Bioactive functional material from plant Leucas cephalotes and Ocimum was
coated as per heavy-duty technical textile coating 700 gm bioactive functional material was applied onto the fabric
Three layers of bioactive functional material from Leucas cephalotes and Ocimum was applied onto the fabric.
In the present invention we developed a nano-scale processing technology that allows molecular arrangement and molecular self-assembly necessary to bring out further advanced functionalities in textile processing than the existing dyeing processing.
Natural dyes obtained from the root bark and flowers of the Leucas cephalotes and Ocimum has shine green , has good stability, minimal aroma, and does not contain any organic solvent residuals is provided.
Some embodiments of the invention have been described above, and in addition, some specific details are shown for purposes of illustrating the inventive principles. However, numerous other arrangements may be devised in accordance with the inventive principles of this patent disclosure. Further, well known processes have not been described in detail in order not to obscure the invention. Thus, while the invention is described in conjunction with the specific embodiments described above, it is not limited to these embodiments or drawings. Rather, the invention is intended to cover alternatives, modifications, and equivalents that come within the scope and spirit of the inventive principles set out above.
What it claimed is:
1. Therapeutic clothing comprising an Organic fabric whose dye with natural colour which have a therapeutic property for the prevention and treatment of Fever, allergy, Excessive (Heat /Cold).
2. The therapeutic clothing claim 1 where the fabric is selected from the clothing that is made from materials that was grown without the use of synthetic chemicals such as pesticides - herbicides or other chemicals.
3. The therapeutic clothing of claim 2 where the fabric is cotton, silk and wool.
4. The therapeutic clothing claim 1 where the therapeutic agents for the prevention and treatment of Fever, allergy, Excessive (Heat /Cold) is the natural colour obtained from the Fruits, Leaves, bark and root of the different species of Lamiaceae family, which includes Leucas cephalotes (Dronpushpi or Guma), Ocimum sanctum (Tulsi).
5. The product of claim 1 where the entire ingredient claimed as therapeutic agent for the dyeing of organic fiber and cloths was tested for their efficacy
by various in-vivo and in-vitro clinical trail the results was very significant on prevention and treatment of Fever, allergy, Excessive (Heat /Cold).
6. A method of making an therapeutic product comprising contacting a fabric dye and treated with an natural colors and other active ingredients from the whole parts of the plant Leucas cephalotes (Dronpushpi or Guma). Ocimum sanctum (Tulsi).
| # | Name | Date |
|---|---|---|
| 1 | 1607-del-2009-abstract.pdf | 2011-08-21 |
| 1 | 1607-DEL-2009-Form-2-(04-08-2010).pdf | 2010-08-04 |
| 2 | 1607-del-2009-description (provisional).pdf | 2011-08-21 |
| 2 | 1607-DEL-2009-Form-1-(04-08-2010).pdf | 2010-08-04 |
| 3 | 1607-DEL-2009-Description (Complete)-(04-08-2010).pdf | 2010-08-04 |
| 3 | 1607-del-2009-form-1.pdf | 2011-08-21 |
| 4 | 1607-DEL-2009-Correspondence-Others-(04-08-2010).pdf | 2010-08-04 |
| 4 | 1607-del-2009-form-2.pdf | 2011-08-21 |
| 5 | 1607-DEL-2009-Claims-(04-08-2010).pdf | 2010-08-04 |
| 6 | 1607-DEL-2009-Correspondence-Others-(04-08-2010).pdf | 2010-08-04 |
| 6 | 1607-del-2009-form-2.pdf | 2011-08-21 |
| 7 | 1607-DEL-2009-Description (Complete)-(04-08-2010).pdf | 2010-08-04 |
| 7 | 1607-del-2009-form-1.pdf | 2011-08-21 |
| 8 | 1607-del-2009-description (provisional).pdf | 2011-08-21 |
| 8 | 1607-DEL-2009-Form-1-(04-08-2010).pdf | 2010-08-04 |
| 9 | 1607-del-2009-abstract.pdf | 2011-08-21 |
| 9 | 1607-DEL-2009-Form-2-(04-08-2010).pdf | 2010-08-04 |